These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3747259)

  • 1. Activities of 2'-5'oligoadenylate synthetase in peripheral blood mononuclear cells of patients with viral hepatitis, and chronic type B hepatitis during interferon therapy.
    Sugawara T; Matsushima T; Miyazaki T; Toyota J; Fujii N; Minagawa T
    Jpn J Med; 1986 May; 25(2):144-8. PubMed ID: 3747259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells obtained from patients with chronic hepatitis B during interferon therapy].
    Sugawara T
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):439-54. PubMed ID: 2227795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitis.
    Karino Y; Sugawara T; Saga A; Yoshida J; Matsushima T; Miyazaki T; Toyota J; Okuuchi Y
    Gastroenterol Jpn; 1989 Apr; 24(2):164-9. PubMed ID: 2744332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B.
    Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y
    Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B.
    Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y
    Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
    J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis.
    Heathcote J; Kim YI; Yim CK; LeBrocq J; Read SE
    Hepatology; 1989 Jan; 9(1):105-9. PubMed ID: 2461889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
    Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon.
    Nakajima S; Kuroki T; Shintani M; Kurai O; Takeda T; Nishiguchi S; Shiomi S; Seki S; Kobayashi K
    Hepatology; 1990 Dec; 12(6):1261-5. PubMed ID: 2147916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
    Ogawa Y
    Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells from patients with fulminant hepatitis.
    Nishino S; Ohnishi H; Muto Y; Moriwaki H; Sakai T; Sugihara J; Saitoh K
    Gastroenterol Jpn; 1989 Jun; 24(3):337. PubMed ID: 2744346
    [No Abstract]   [Full Text] [Related]  

  • 12. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance].
    Komiyama T; Akaike M; Satomura K; Okumura H
    Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.
    Jakschies D; Zachoval R; Müller R; Manns M; Nolte KU; Hochkeppel HK; Horisberger MA; Deicher H; Von Wussow P
    Hepatology; 1994 Apr; 19(4):857-65. PubMed ID: 8138257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of 2, 5-oligoadenylate synthetase in non-A, non-B hepatitis].
    Karino Y; Sugawara T; Saga A; Matsushima T; Miyazaki T
    Nihon Rinsho; 1988 Dec; 46(12):2715-9. PubMed ID: 2468003
    [No Abstract]   [Full Text] [Related]  

  • 15. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases.
    Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN
    Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173
    [No Abstract]   [Full Text] [Related]  

  • 16. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
    Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G
    J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase.
    Nishiguchi S; Kuroki T; Otani S; Takeda T; Hirota S; Shimizu Y; Nakajima S; Saito S; Shiomi S; Kobayashi K
    Hepatology; 1989 Jul; 10(1):29-33. PubMed ID: 2472340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive immunoenzymometric assay for 2',5'-oligoadenylate. Detection of elevated 2',5'-oligoadenylate synthetase in human peripheral mononuclear cells.
    Johnston MI; Preble OT; Imai J; Jacobsen H; Torrence PF
    J Immunol Methods; 1983 Dec; 65(1-2):123-35. PubMed ID: 6361140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant leukocyte interferon on ribonuclease activities in serum in chronic hepatitis B.
    Tsuji H; Murai K; Akagi K; Fujishima M
    Clin Chem; 1990 Jun; 36(6):913-6. PubMed ID: 2357834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
    Hirai N; Shimizu M; Morioka T; Hinoue Y; Tanaka N; Kobayashi K; Hattori N; Hashimoto T
    Liver; 1988 Jun; 8(3):138-45. PubMed ID: 3393063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.